XERS

XERS

USD

Xeris Biopharma Holdings Inc. Common Stock

$9.900+0.356 (3.730%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$9.544

Máximo

$10.020

Mínimo

$9.480

Volumen

3.39M

Fundamentos de la Empresa

Capitalización de Mercado

1.6B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

2.51M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $2.82Actual $9.900Máximo $10.03

Noticias Relacionadas

BusinessWire

Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025

Conference Call to be Held at 8:30 a.m. ET Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative

Ver más
Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025
BusinessWire

Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today

Ver más
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)